| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
164.95(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 20.7 |
| Insider 6 Months : 20.7 |
| Insider 3/6 Months : 41.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
23,588,234 |
23,588,234 |
23,684,920 |
36,697,977 |
| Total Buy Value |
$20,049,999 |
$20,049,999 |
$20,186,326 |
$42,821,288 |
| Total People Bought |
2 |
2 |
2 |
8 |
| Total Buy Transactions |
2 |
2 |
3 |
13 |
| Total Shares Sold |
0 |
0 |
96,686 |
455,706 |
| Total Sell Value |
$0 |
$0 |
$136,327 |
$650,097 |
| Total People Sold |
0 |
0 |
1 |
6 |
| Total Sell Transactions |
0 |
0 |
1 |
21 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Horner Larry D /fa |
Director |
– • – |
2013-08-13 |
4 |
A |
$0.00 |
$51,264 |
D/D |
60,346 |
64,425 |
|
- |
|
| Kasser Thomas R. |
SVP--Food Sector |
• – – |
2013-08-13 |
4 |
B |
$16.00 |
$80,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2013-08-13 |
4 |
B |
$16.00 |
$528,000 |
D/D |
33,000 |
56,300 |
2.39 |
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2013-08-13 |
4 |
A |
$0.00 |
$11,952 |
D/D |
19,432 |
23,300 |
|
- |
|
| Reed Thomas D. |
Chief Science Officer |
• • – |
2013-08-13 |
4 |
B |
$16.00 |
$28,800 |
I/I |
1,800 |
1,800 |
2.66 |
- |
|
| Reed Thomas D. |
Chief Science Officer |
• • – |
2013-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
900 |
79,340 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,501,600 |
I/I |
1,696,140 |
76,611 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,579,760 |
I/I |
1,880,737 |
73,668 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$4,788,448 |
I/I |
5,399,630 |
131,081 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,928 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,851 |
|
- |
|
| Reed Thomas D. |
Chief Science OfficerOfficer |
• • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
331,405 |
|
- |
|
| Frank Steven |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,795 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,872 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,851 |
|
- |
|
| Horner Larry D /fa |
Director |
– • – |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,083 |
|
- |
|
| Kirk Randal J |
Chief Executive OfficerOfficer |
• • • |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,375,298 |
|
- |
|
692 Records found
|
|
Page 28 of 28 |
|
|
0.04 (4.5%) 
